Detalhe da pesquisa
1.
Enhancing diversity of clinical trial populations in multiple sclerosis.
Mult Scler
; 29(9): 1174-1185, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37555490
2.
Foot Melanoma Localized to Subungual Toe Location Portends Poorer Prognosis.
J Foot Ankle Surg
; 62(5): 840-844, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37169120
3.
Ponseti Idiopathic and Nonidiopathic Clubfoot Correction With Secondary Surgeries.
J Foot Ankle Surg
; 60(4): 742-746, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789808
4.
Microorganisms Associated With Osteomyelitis of the Foot and Ankle.
J Foot Ankle Surg
; 59(3): 491-494, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32354506
5.
Melanoma of the Foot Is Associated With Advanced Disease and Poorer Survival.
J Foot Ankle Surg
; 57(1): 52-55, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29037928
6.
Improvement of driving skills in persons with relapsing-remitting multiple sclerosis: a pilot study.
Arch Phys Med Rehabil
; 95(3): 531-7, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24161271
7.
Walking and physical performance in black and white adults with multiple sclerosis controlling for social determinants of health.
Mult Scler Relat Disord
; 83: 105439, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38219300
8.
A review of Bruton's tyrosine kinase inhibitors in multiple sclerosis.
Ther Adv Neurol Disord
; 17: 17562864241233041, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38638671
9.
Disparities by Race in Pregnancy Care and Clinical Outcomes in Women With Multiple Sclerosis: A Diverse Multicenter Cohort
Neurology
; 102(4): e208100, 2024 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261988
10.
Predictors of driving in individuals with relapsing-remitting multiple sclerosis.
Mult Scler
; 19(3): 344-50, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22760100
11.
Impact of adherence to disease modifying therapies on long-term clinical and economic outcomes in multiple sclerosis: A claims analysis of real-world data.
Mult Scler Relat Disord
; 77: 104866, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37487345
12.
Diversity, Equity, and Inclusion in the Multiple Sclerosis Community: A Call to Action.
Int J MS Care
; 25(5): 199-205, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37720263
13.
The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment.
Neurol Ther
; 12(5): 1491-1515, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37450172
14.
Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM.
Neurol Ther
; 12(5): 1669-1682, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37354276
15.
Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial.
Mult Scler Relat Disord
; 76: 104794, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356256
16.
Advancing Care and Outcomes for African American Patients With Multiple Sclerosis.
Neurology
; 98(24): 1015-1020, 2022 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35470139
17.
Generating real-world data from health records: design of a patient-centric study in multiple sclerosis using a commercial health records platform.
JAMIA Open
; 5(1): ooab110, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35155999
18.
Social determinants of health in multiple sclerosis.
Nat Rev Neurol
; 18(12): 723-734, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369488
19.
Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials.
Ethn Dis
; 32(1): 61-68, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35106045
20.
Efficacy and safety of ocrelizumab vs interferon beta-1a in participants of African descent with relapsing multiple sclerosis in the Phase III OPERA I and OPERA II studies.
Mult Scler Relat Disord
; 52: 103010, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34147885